Sign inJoin waitlistJoin the waitlist

AS

Abid Siddiqui

Chief Operating Officer and Board Director, Affineon Health · DREXEL UNIVERSITY

Credentials: ·

History

Affineon Health · DREXEL UNIVERSITY
Present

Residency
2025–2028
Medical School
2021–2025

Research

A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing
Nature Communications · 2020 · 89 citations
Case Report: IVC-agenesis and FVL mutation; successful DVT/PE treatment with direct oral anticoagulation (factor Xa inhibitor)
Case report · Frontiers in Cardiovascular Medicine · 2025 · First of 4 authors · Corresponding
miR-21 Expression Determines the Early Vaccine Immunity Induced by LdCen-/- Immunization
Frontiers in Immunology · 2019

Abhay Satoskar
1 paper
Sanika Satoskar
1 paper
WW
Waris Waris
1 paper